David Hart Appointed to CEO andJesse Channonto President

Nicholas Vitato Retire and Will Continue to Serve as Member of Board of Directors

NEW YORK--(BUSINESS WIRE)--Jan. 15, 2024--The Cannabist Company Holdings Inc.(NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in theU.S., announced today that, effective immediately, the Company’s Board of Directors (the “Board”) has appointedDavid Hart, previously the Company’s President and Chief Operating Officer, as the new Chief Executive Officer. The Board also appointedJesse Channon, previously the Company’s Chief Commercial Officer, as President.Nicholas Vitawill continue to serve as a Director of the Company.

“We all owe Nick a debt of gratitude for having the vision to form what is nowThe Cannabist Companymore than a decade ago. It was his passion for serving people through cannabis that brought together the best teams and partners to deliver on the promise for our patients and customers. I have had the great pleasure of working with Nick at this Company since 2016, and it is my humble honor to take the reins as CEO, working alongside a tremendously talented leadership team. The strength of the team and continued commitment to serving our communities will carry us into this next exciting chapter. We have implemented strategic organizational changes in recent quarters that have prepared us for this change. We are excited for what lies ahead and eager to continue the progress asThe Cannabist Companyevolves, from continuing to strengthen the balance sheet to expanding our wholesale program and driving organic growth,” saidDavid Hart, Chief Executive Officer ofThe Cannabist Company.

Vita co-foundedThe Cannabist Company, formerlyColumbia Care, in 2012 when he became the Company’s first employee. He has served as its Chief Executive Officer since then. Under his leadership, the Company has grown to thousands of employees, encompasses 16 fully integrated markets in theU.S., generates more than$500 millionin annual revenue, went public on a senior exchange inCanada, and serves countless patients and customers with high-quality products across the national portfolio.

“The Cannabist Company would not exist as it does today without Nick and his fortitude to lead us through the peaks and valleys of running a cannabis company. His passion is infused in everything we do, and we are looking forward to building on those commitments we’ve made to bring a higher experience to everyone we serve and support, both internally and externally. I am incredibly proud to be stepping into this role and to have the opportunity to further shape and define our place as a leader in the cannabis industry,” saidJesse Channon, President ofThe Cannabist Company.

“This decision to retire was not made lightly. Having been the longest serving CEO in the history of the industry, I am grateful to my team and our employees for their years of dedication, professionalism, and tenacity. As the first employee, I have seen this company reach new heights and overcome tremendous challenges over the past 12 years. I am proud of the company we’ve built and am confident in the skilled leadership that will now steer the ship. Although my next endeavor is focused on the incredibly important, and deeply personal, task of groundbreaking research for ultrarare pediatric diseases via a gene therapy platform I helped to develop, I am pleased to remain on as a member of the Board of Directors and will continue to support the Company as it enters this next chapter,” saidNicholas Vita, Co-Founder.

“Founder, strategist, tactician, Nick poured his heart and soul into the company. His strategic guidance over the past 12 years paved the way for the exciting chapters ahead under David and Jesse’s leadership,” saidJames A.C. Kennedy, member of the Board of Directors at the Company.

David HartjoinedThe Cannabist Companyin 2016 and became Chief Operating Officer in 2018. Prior to joiningThe Cannabist Company, David served as Chief Operating Officer of Abyrx, a venture capital-backed medical device company that developed, manufactured, and commercialized a portfolio of intraoperative cross specialty hemostats. Prior to his time at Abyrx, David was Chief Financial Officer and Chief Investment Officer atAlpine Capital, a family investment office for theRanawat Orthopedic Groupat theHospital for Special Surgery, where he was responsible for capital allocations, direct private investments, and all healthcare investments. David was also previously the Partner and Head of Healthcare Equity Investments atApelles Investment Management. David started his career in the financial services industry in the Mergers and Acquisitions groups atThomas Weisel Partnersand Duff & Phelps. David has an MBA fromColumbia Universityand is a graduate ofDuke University.

Jesse ChannonjoinedThe Cannabist CompanyinDecember 2019as Chief Growth Officer. Jesse is an accomplished and award-winning leader with a background in developing transformative technologies and digital marketing platforms, having advised and worked with some of the largest brands and agencies in the world. A member of the founding team at PageLever, a Y Combinator-backed company, Jesse oversaw all revenue and partnerships, working with companies such as YouTube, Microsoft, Intel andToyotato build one of the first real-time applications on Facebook’s API and earning certification in the first wave of Preferred Marketing Developers. In 2013, PageLever sold to Unified, aNew York City-based Ad Tech company, where Jesse spent six years on the senior management team. After Unified, Jesse served as Chief Revenue Officer for Social Native, a custom content marketplace. Jesse also serves on theEntrepreneurship Advisory Boardfor theHarbert School of Businessat his alma materAuburn University.

AboutThe Cannabist Company(f/k/aColumbia Care)

The Cannabist Company, formerly known asColumbia Care, is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 16 U.S. jurisdictions. The Company operates 125 facilities including 94 dispensaries and 31 cultivation and manufacturing facilities, including those under development.The Cannabist Companyis one of the original multi-state providers of cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit www.cannabistcompany.com.

Caution Concerning Forward Looking Statements

This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the future of the Company, the Company’s management, and the Company’s ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. In addition, securityholders should review the risk factors discussed under “Risk Factors” in the Company’s Form 10-K for the year endedDecember 31, 2022, as filed with Canadian andU.S.securities regulatory authorities and described from time to time in subsequent documents filed with applicable securities regulatory authorities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240115957035/en/

Investors
Lee Ann Evans
SVP, Capital Markets
investor@cannabistcompany.com

Media
Lindsay Wilson
SVP, Communications
media@cannabistcompany.com

Source:The Cannabist Company Holdings Inc.